What the study examined
A research team used retinal tissue from the rd1 mouse, a laboratory model of inherited retinal degeneration caused by a mutation in the Pde6b gene, to examine whether metabolic signaling pathways could affect photoreceptor survival. The work focused on PPAR proteins—PPARα, PPARγ and PPARβ/δ—and PGC-1α, a regulator associated with cellular energy metabolism and mitochondrial function.
This is relevant to retinitis pigmentosa (RP) research because photoreceptors have substantial energy needs, and changes in cellular metabolism are being investigated as one possible contributor to degeneration. RP is genetically diverse, and the study evaluated one mouse model rather than people with RP.
What researchers reported
The investigators grew rd1 retinal tissue in organotypic explant culture, meaning retinal samples were maintained outside the body for experimental testing. They tested compounds intended to activate individual PPAR pathways, as well as approaches that activated or inhibited PGC-1α.
According to the paper, treatments directed at PPARα, PPARγ and PGC-1α were associated with fewer dying photoreceptors in the cultured rd1 retinas. The researchers measured cell death with a TUNEL assay. They also reported reduced activity of PARP, an enzyme that can consume NAD+ when overactivated.
In contrast, PPARβ/δ agonists had limited effects in this experimental system. The study also found that activating sirtuin-1, an upstream regulator of PGC-1α, did not improve photoreceptor viability on its own. A benefit was reported only when sirtuin-1 stimulation was paired with PARP inhibition.
The authors further reported that PPARγ and PGC-1α activation reduced overall calpain activity and excessive activation of calpain-2. Calpains are enzymes influenced by calcium, and the paper links their overactivity with photoreceptor degeneration in the rd1 model. Gene-expression testing found increases in genes described as downstream of PGC-1α/PPAR signaling after treatment.
Why the findings may matter
The study provides preclinical evidence supporting a possible connection between energy-related signaling, PARP activity, calcium-related calpain activity and photoreceptor loss in rd1 retinal tissue. The researchers propose a feedback-control model involving PARP, sirtuin-1, PGC-1α and PPARs. Within their experiments, PPARα, PPARγ and PGC-1α appeared to work cooperatively in association with photoreceptor protection.
For the inherited retinal disease community, the work adds to research exploring mechanisms that may be relevant across some forms of retinal degeneration, beyond approaches directed at a single disease-causing gene. However, the paper does not establish that targeting these pathways will preserve vision or benefit people with RP.
Important limitations
This was an early-stage laboratory study in retinal explants from one mouse model. Results from isolated mouse retinal tissue may not translate to living animals or to human retinas. The supplied report does not describe testing in people, clinical trial results, visual-function outcomes, long-term effects, or the safety of any proposed treatment approach.
The rd1 model reflects degeneration associated with a specific Pde6b mutation, while RP can result from many different genes and disease mechanisms. The reported findings therefore should be viewed as mechanistic and preclinical evidence that could inform further research, rather than as a treatment update for patients.
Publisher source
Nature, published September 14, 2026: PGC-1α and PPARs cooperatively mediate photoreceptor neuroprotection in rd1 mouse inherited retinal degeneration